MINI MICHAEL to Hyperoxaluria, Primary
This is a "connection" page, showing publications MINI MICHAEL has written about Hyperoxaluria, Primary.
Connection Strength
2.169
-
Diagnosis and management of primary hyperoxalurias: best practices. Pediatr Nephrol. 2024 Nov; 39(11):3143-3155.
Score: 0.938
-
Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial. Am J Kidney Dis. 2023 Feb; 81(2):145-155.e1.
Score: 0.826
-
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trial. Pediatr Nephrol. 2023 04; 38(4):1075-1086.
Score: 0.207
-
Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young children. Genet Med. 2022 03; 24(3):654-662.
Score: 0.198